Search Results
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Marra Jai Aghajani in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Tara Laurine Roberts in
Google Scholar
PubMed
Saint Vincent’s Clinical School, UNSW Sydney, Sydney, Australia
SydPath, Saint Vincent’s Hospital, Sydney, Australia
Search for other papers by Tao Yang in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Charles Eugenio McCafferty in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Centre for Oncology Education and Research Translation (CONCERT), Liverpool, New South Wales, Australia
Search for other papers by Nicole J Caixeiro in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Paul DeSouza in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Department of Head & Neck Surgery, Liverpool Hospital, Liverpool, New South Wales, Australia
Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Search for other papers by Navin Niles in
Google Scholar
PubMed
, 24 , 26 , 27 , 28 , 29 ). There are a number of reasons why sPD-L1 may provide different information and potentially a broader measure of systemic inflammation state than tumour PD-L1 levels and these are discussed further below. In the present
Search for other papers by Maria Stelmachowska-Banaś in
Google Scholar
PubMed
Search for other papers by Izabella Czajka-Oraniec in
Google Scholar
PubMed
dysfunction (hypopituitarism), with some cases exhibiting enlargement causing a mass effect. Epidemiology Pituitary inflammation as a primary condition (e.g. lymphocytic hypophysitis) or secondary to systemic diseases, such as systemic lupus
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
persist. NASH is characterized morphologically by steatosis, ballooning hepatocytes, inflammation, with or without fibrosis. NASH itself can continue to progress to cirrhosis and hepatocellular carcinoma ( 17 , 18 ). NAFLD can be considered as the
Search for other papers by Myrian Velasco in
Google Scholar
PubMed
Search for other papers by Rosa Isela Ortiz-Huidobro in
Google Scholar
PubMed
Search for other papers by Carlos Larqué in
Google Scholar
PubMed
Search for other papers by Yuriko Itzel Sánchez-Zamora in
Google Scholar
PubMed
Search for other papers by José Romo-Yáñez in
Google Scholar
PubMed
Search for other papers by Marcia Hiriart in
Google Scholar
PubMed
down-regulate the insulin pathway ( 19 ). Under conditions of nutrient overload, the increase in protein S6 kinase 1 (P70S6K1) levels in human visceral adipose tissue participates in the development of insulin resistance and inflammation ( 20 ). An
Search for other papers by Madalena von Hafe in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar São João, Porto, Portugal
Search for other papers by João Sergio Neves in
Google Scholar
PubMed
Search for other papers by Catarina Vale in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar São João, Porto, Portugal
Search for other papers by Marta Borges-Canha in
Google Scholar
PubMed
Search for other papers by Adelino Leite-Moreira in
Google Scholar
PubMed
sensitivity to the adrenergic system by increasing the number of adrenergic membrane receptors. Additionally, T3 decreases systemic vascular resistance through vascular smooth-muscle relaxation, which in turn decreases renal perfusion and leads to renin
Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed
Search for other papers by Kathrin H Popp in
Google Scholar
PubMed
Search for other papers by Gunter Karl Stalla in
Google Scholar
PubMed
medications. The psychiatric treatment at this time included behavior therapy initially in the outpatient unit and later on systemic psychotherapy in the psychiatric ward without medical treatment. Quinagolide was applied for a total of about two years (03
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Christine Rode Andreasen in
Google Scholar
PubMed
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Andreas Andersen in
Google Scholar
PubMed
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip Krag Knop in
Google Scholar
PubMed
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
exert a direct effect on the heart and blood vessels ( 6 ) and an indirect effect via improved glycaemia ( 24 ), a reduction in blood pressure and postprandial rise in triglycerides ( 25 ), a reduction in markers of oxidative stress and systemic
Search for other papers by Herjan J T Coelingh Bennink in
Google Scholar
PubMed
Search for other papers by Jan Krijgh in
Google Scholar
PubMed
Search for other papers by Jan F M Egberts in
Google Scholar
PubMed
Search for other papers by Maria Slootweg in
Google Scholar
PubMed
Search for other papers by Harm H E van Melick in
Google Scholar
PubMed
Search for other papers by Erik P M Roos in
Google Scholar
PubMed
Search for other papers by Diederik M Somford in
Google Scholar
PubMed
Search for other papers by Yvette Zimmerman in
Google Scholar
PubMed
Search for other papers by Iman J Schultz in
Google Scholar
PubMed
Search for other papers by Noel W Clarke in
Google Scholar
PubMed
Search for other papers by R Jeroen A van Moorselaar in
Google Scholar
PubMed
Search for other papers by Frans M J Debruyne in
Google Scholar
PubMed
are bisphosphonates, denosumab or selective estrogen receptor modulators (SERMs) ( 13 ). However, these compounds may have side effects. Both short-term (e.g. hypocalcemia or ocular inflammation) and long-term (e.g. osteonecrosis or atrial fibrillation
Division of Endocrinology, Division of Nephrology, Endocrine Research Laboratory, Department of Medicine
Division of Endocrinology, Division of Nephrology, Endocrine Research Laboratory, Department of Medicine
Division of Endocrinology, Division of Nephrology, Endocrine Research Laboratory, Department of Medicine
Search for other papers by Hershel Raff in
Google Scholar
PubMed
Search for other papers by Hariprasad Trivedi in
Google Scholar
PubMed
overlap of this variable between the two ESRD subgroups. Subjects with chronic kidney disease have elevated markers of inflammation that are associated with a range of abnormalities including resistance to erythropoiesis-stimulating agents and increased
Search for other papers by M Boering in
Google Scholar
PubMed
Isala, Department of Internal Medicine, Zwolle, The Netherlands
Search for other papers by P R van Dijk in
Google Scholar
PubMed
Langerhans Medical Research group, Zwolle, The Netherlands
Search for other papers by S J J Logtenberg in
Google Scholar
PubMed
Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by K H Groenier in
Google Scholar
PubMed
Search for other papers by B H R Wolffenbuttel in
Google Scholar
PubMed
Search for other papers by R O B Gans in
Google Scholar
PubMed
Langerhans Medical Research group, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by N Kleefstra in
Google Scholar
PubMed
Isala, Department of Internal Medicine, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by H J G Bilo in
Google Scholar
PubMed
and prolactin . Journal of Clinical Endocrinology and Metabolism 1988 67 460 – 464 . ( doi:10.1210/jcem-67-3-460 ) 18 Radziuk J Pye S Seigler DE Skyler JS Offord R Davies G. Splanchnic and systemic absorption of intraperitoneal